We had such a great time celebrating 25 years with all of you. The first highlight of the year was connecting with colleagues at ADCES in Houston. It was like … Continue reading 2023 – A Year of Celebrations
AR is 15 years old and uses an automated insulin delivery (AID) system to manage their diabetes. They tell you they feel so guilty about all the food and sweets … Continue reading Question of the Week | Post Holiday Guilt – How to address?
This year was an exciting one at the Cat Bakery, filled with lots of love, joy, and a bit of magic. Last year I shared our newest addition to the … Continue reading Happy Holidays from the Cat Bakery
Based on the newly released 2024 American Diabetes Association (ADA) Standards of Care, which of the following statements is NOT accurate regarding treatment for hyperglycemia? Click Here to Test your … Continue reading Question of the Week | New ADA 2024 Standards – Meds for Type 2 Diabetes
Be a part of our diabetes community while learning about the latest in diabetes care. Plus, Coach Beverly provides an interactive question and answer session at the end of each … Continue reading Upcoming webinars | How to Assess Well-Being & Meds Management for Type 2 Diabetes
For last week’s practice question, we quizzed participants on what is the difference between a CDCES & BC-ADM. 57% of respondents chose the best answer. We want to clarify and … Continue reading Rationale of the Week | What is the difference between CDCES vs. BC-ADM?
The U.S. Food and Drug Administration approved tirzepatide (Zepbound) injection for chronic weight management in adults with a BMI of 30 or with a BMI of 27 or greater with … Continue reading Tirzepatide approved for weight loss